Acumen Pharmaceuticals Inc Q3 2024 Earnings Call Highlights Strong Cash Position and ...
| NSHD Index | 2,628 612.00 30.36% |
About 51% of NYSE Declining's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding NYSE Declining Stocks suggests that some traders are interested. NYSE Declining's investing sentiment overview a quick insight into current market opportunities from investing in NYSE Declining Stocks. Many technical investors use NYSE Declining Stocks index news signals to limit their universe of possible portfolio assets and to time the market correctly.
Cash and Marketable Securities 259 million as of September 30, 2024.Cash Runway Expected to last into the first half of 2027.RD Expenses 27.2 million in
Read at gurufocus.com
 |
NYSE Declining Stocks Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NYSE Declining index to make a market-neutral strategy. Peer analysis of NYSE Declining could also be used in its relative valuation, which is a method of valuing NYSE Declining by comparing valuation metrics with similar companies.
Peers
NYSE Declining Related Equities
| VALN | Valneva SE | 0.54 | ||||
| INBX | Inhibrx | 0.07 | ||||
| ABCL | Abcellera Biologics | 2.45 | ||||
| DFS | Discover Financial | 3.23 | ||||
| CPRX | Catalyst Pharmaceuticals | 3.26 | ||||
| WU | Western Union | 3.50 | ||||
| CNTA | Centessa Pharmaceuticals | 6.19 | ||||
| ABOS | Acumen Pharmaceuticals | 8.67 |